Complement receptor type two (CR2,CR21)A target for influencing the humoral immune response and antigen-trapping

被引：0
|
作者：
Wolfgang M. Prodinger
机构：
[1] University of Innsbruck,Institut für Hygiene
来源：
Immunologic Research | 1999年 / 20卷
关键词：
Complement; C3; Receptor; CD21; Structure; Immunity; EBV; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cellular receptors for complement C3 fragments deposited on antigens are important bricks in the wall defending against microbial pathogens. The part of complement receptor type 2 (CR2; CD21) deals with enhancing humoral immune responses and with long-term trapping of C3d-coated antigen by follicular dendritic cells. CR2 is also pivotal for Epstein-Barr virus (EBV) infection. Here, the current understanding, how CR2 interacts with its ligands C3d, EBV, and CD23 is summarized. The potential to target CR2 for clinical therapy or immunization purposes are discussed.
引用
收藏
页码：187 / 194
页数：7
相关论文
共 50 条
  • [21] A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation
    Makar, KW
    Ulgiati, D
    Hagman, J
    Holers, VM
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (05) : 657 - 664
  • [22] Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists
    Kulik, Liudmila
    Chen, Kuan
    Huber, Brigitte T.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2011, 48 (6-7) : 883 - 894
  • [23] Role of complement receptors type 2 (CR2/CD21) and 1 (CR1/CD35) in murine lupus
    Holers, VM
    Boackle, SA
    Jiang, N
    Jeong, CH
    Molina, H
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 355 - 355
  • [24] Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity
    Diep, Nguy Thi
    Giang, Ngo Truong
    Diu, Nguyen Thi Thuy
    Nam, Nguyen Minh
    Van Khanh, Le
    Van Quang, Ha
    Hang, Ngo Thu
    Van Mao, Can
    Van Son, Ho
    Hieu, Nguyen Lan
    Linh, Phan Tung
    Sklan, Ella H.
    Toan, Nguyen Linh
    Van Tong, Hoang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] Complement receptor type 1 and 2 (CR1 and CR2) gene polymorphisms and plasma protein levels are associated with the Dengue disease severity
    Nguy Thi Diep
    Ngo Truong Giang
    Nguyen Thi Thuy Diu
    Nguyen Minh Nam
    Le Van Khanh
    Ha Van Quang
    Ngo Thu Hang
    Can Van Mao
    Ho Van Son
    Nguyen Lan Hieu
    Phan Tung Linh
    Ella H. Sklan
    Nguyen Linh Toan
    Hoang Van Tong
    Scientific Reports, 13
  • [26] Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3
    Twohig, Jason
    Kulik, Liudmila
    Haluszczak, Catherine
    Reuter, Jason
    Rossbach, Andreas
    Bull, Melanie
    Holers, V. Michael
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2007, 44 (13) : 3434 - 3444
  • [27] Complement receptor CR2/CD21 proximal promoter activity is critically dependent upon a cell type specific repressor.
    Ulgiati, D
    Holers, VM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S203 - S203
  • [28] A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease
    Kulik, Liudmila
    Hewitt, Finnegan B.
    Willis, Van C.
    Rodriguez, Rosa
    Tomlinson, Stephen
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2015, 63 (02) : 479 - 488
  • [29] Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: Characterization of basal transcriptional mechanisms
    Ulgiati, D
    Pham, C
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2002, 168 (12): : 6279 - 6285
  • [30] Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)
    Young, Kendra A.
    Chen, Xiaojiang S.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (50) : 36614 - 36625
12345